Middle East Healthcare Co (SAU:4009) Altman Z2-Score: 2.31 (As of Jul. 24, 2026) — 13% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4009 Middle East Healthcare Co SAU:4009
79 GF Score
Price ﷼30.28
GF Value ﷼80.23
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Middle East Healthcare Co Altman Z2-Score?

Middle East Healthcare Co SAU:4009 +0.60% 79 Altman Z2-Score is 2.31 as of Jul. 24, 2026, which is 13% below its 10-year median of 2.65. GuruFocus rates SAU:4009 with a GF Score™ of 79/100 and a GF Value™ of ﷼80.23 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 671 Healthcare Providers & Services companies, Middle East Healthcare Co ranks better than 50.82% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Middle East Healthcare Co has a Altman Z2-Score of 2.31, indicating it is in Grey Zones. This implies that Middle East Healthcare Co is in some kind of financial stress. If it is below 1.1, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Middle East Healthcare Co's Altman Z2-Score or its related term are showing as below:

SAU:4009' s Altman Z2-Score Range Over the Past 10 Years
Min: 1.06   Med: 2.65   Max: 5.56
Current: 2.31

During the past 11 years, Middle East Healthcare Co's highest Altman Z2-Score was 5.56. The lowest was 1.06. And the median was 2.65.


Middle East Healthcare Co  (SAU:4009) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Middle East Healthcare Co Altman Z2-Score Related Terms


Middle East Healthcare Co Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Middle East Healthcare Co's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Middle East Healthcare Co Altman Z2-Score Chart

Middle East Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.06 1.30 1.44 2.66 2.59

Middle East Healthcare Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.25 2.90 2.69 2.59 2.31

SAU:4009 vs HCA, THC, DVA: Altman Z2-Score Comparison

For the Medical Care Facilities subindustry, Middle East Healthcare Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Middle East Healthcare Co Altman Z2-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Middle East Healthcare Co's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Middle East Healthcare Co's Altman Z2-Score falls into.


SAU:4009
79GF Score
Middle East Healthcare Co SAU:4009
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Middle East Healthcare Co Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Middle East Healthcare Co's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.128+3.26*0.1374+6.72*0.0677+1.05*0.5401
=2.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was ﷼5,468 Mil.
Total Current Assets was ﷼2,168 Mil.
Total Current Liabilities was ﷼1,468 Mil.
Retained Earnings was ﷼751 Mil.
Pre-Tax Income was 29.99 + 34.003 + 51.872 + 71.643 = ﷼188 Mil.
Interest Expense was -43.077 + -42.094 + -48.005 + -49.45 = ﷼-183 Mil.
Total Liabilities was ﷼3,515 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(2167.892 - 1468.15)/5467.522
=0.128

X2=Retained Earnings/Total Assets
=751.301/5467.522
=0.1374

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(187.508 - -182.626)/5467.522
=0.0677

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(1898.165 - 0)/3514.644
=0.5401

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Middle East Healthcare Co has a Altman Z2-Score of 2.31 indicating it is in Grey Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 2.31 mean?
Middle East Healthcare Co (SAU:4009) has a Altman Z2-Score of 2.31 as of Jul. 24, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Middle East Healthcare Co and its competitors. This is 13% below median its historical median of 2.65. Over the past decade, Middle East Healthcare Co's Altman Z2-Score has ranged from 1.06 to 5.56. According to the industry distribution chart, Middle East Healthcare Co ranks #330 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 49.2%.
Is Middle East Healthcare Co's Altman Z2-Score too high?
Middle East Healthcare Co's current Altman Z2-Score of 2.31 is 13% below median its 10-year median of 2.65. Over the past 10 years, this metric has ranged from a low of 1.06 to a high of 5.56. The Healthcare Providers & Services industry median Altman Z2-Score is 2.20. Middle East Healthcare Co's value of 2.31 is 5% above this industry median. Based on the distribution chart, Middle East Healthcare Co ranks #330 out of 671 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Middle East Healthcare Co has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's Altman Z2-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Middle East Healthcare Co ranks #330 out of 671 companies for Altman Z2-Score. This puts Middle East Healthcare Co in the upper half of its industry. The industry median Altman Z2-Score is 2.20. Middle East Healthcare Co's value of 2.31 is 5% above this benchmark. Historically, Middle East Healthcare Co's own Altman Z2-Score has ranged from 1.06 to 5.56 over the past decade. While the company's 10-year median is 2.65 vs. the industry median of 2.20, Middle East Healthcare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.20, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Middle East Healthcare Co's current Altman Z2-Score of 2.31 is 5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Middle East Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Middle East Healthcare Co's current Altman Z2-Score is 2.31, which is 13% below median its own 10-year median of 2.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼80.23, compared to a current price of ﷼30.28 — trading 62.3% below its estimated fair value. The current Altman Z2-Score is 2.31, which is 13% below median its 10-year median of 2.65 and 5% above the Healthcare Providers & Services industry median of 2.20. Middle East Healthcare Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current Altman Z2-Score is 2.31 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?

Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued. The current stock price of ﷼30.28 is trading 62.3% below its estimated GF Value™ of ﷼80.23. GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.

Key valuation signals for SAU:4009:

  • Altman Z2-Score: 2.31 (13% below median its 10-year median of 2.65)
  • GF Value™: ﷼80.23 vs. price of ﷼30.28 (62.3% below fair value)
  • GF Score™: 79/100 with 5 warning signs
  • Industry Position: 5% above the Healthcare Providers & Services median (#330 of 671)

No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Middle East Healthcare Co Business Description

Address 4, Batterjee Road, P.O.Box 2550, Al-Zahra District, Jeddah, SAU, 21461
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
79GF Score

Get the complete analysis for SAU:4009

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼30.28
Price
﷼80.23
GF Value